<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1B116AEE-BBD8-4B73-93CF-DCB8A5573C94"><gtr:id>1B116AEE-BBD8-4B73-93CF-DCB8A5573C94</gtr:id><gtr:name>National University of Singapore</gtr:name><gtr:address><gtr:line1>National University of Singapore</gtr:line1><gtr:line2>10 Kent Ridge Crescent</gtr:line2><gtr:line4>Singapore</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Singapore</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1B116AEE-BBD8-4B73-93CF-DCB8A5573C94"><gtr:id>1B116AEE-BBD8-4B73-93CF-DCB8A5573C94</gtr:id><gtr:name>National University of Singapore</gtr:name><gtr:address><gtr:line1>National University of Singapore</gtr:line1><gtr:line2>10 Kent Ridge Crescent</gtr:line2><gtr:line4>Singapore</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Singapore</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4FC6BDAD-239D-4705-857B-6EDB907549F6"><gtr:id>4FC6BDAD-239D-4705-857B-6EDB907549F6</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Pike</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_13031"><gtr:id>3ADAE7A0-7330-4FB1-98A2-1EA4423CDEA0</gtr:id><gtr:title>Biomedical Catalyst ? Q-CANCER: development of a sample to result device for low cost, rapid tumour profiling</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MC_PC_13031</gtr:grantReference><gtr:abstractText>This project is concerned with the development of a fully integrated, low test cost, sample to result medical device that will enable a histopathologist (or a technician) to perform multiplex genotyping and tumour staging &amp;amp; profiling, within minutes, from formalin fixed &amp;amp;/or fresh tissue samples, providing a molecular adjunct to a histopathologist's standard practice. The device will automate sample prep &amp;amp; DNA sequencing at the press of a single button, following the introduction of a sample. The tissue sample is processed using a number of novel &amp;amp; innovative but proven microfluidic and nanotechnologies that allow for massive multiplexing potential. The device will enable fast turnaround of high quality genotyping that integrates with established clinical practice. Furthermore, the ability to rapidly profile &amp;amp; stage a tumour or identify genetic mutations will lead to improvements in patient outcomes, reduce patient anxiety &amp;amp; result in cost savings in treatment programmes</gtr:abstractText><gtr:technicalSummary>This project is concerned with the development of a fully integrated, low test cost, sample to result medical device that will enable a histopathologist (or a technician) to perform multiplex genotyping and tumour staging &amp;amp; profiling, within minutes, from formalin fixed &amp;amp;/or fresh tissue samples, providing a molecular adjunct to a histopathologist's standard practice. The device will automate sample prep &amp;amp; DNA sequencing at the press of a single button, following the introduction of a sample. The tissue sample is processed using a number of novel &amp;amp; innovative but proven microfluidic and nanotechnologies that allow for massive multiplexing potential. The device will enable fast turnaround of high quality genotyping that integrates with established clinical practice. Furthermore, the ability to rapidly profile &amp;amp; stage a tumour or identify genetic mutations will lead to improvements in patient outcomes, reduce patient anxiety &amp;amp; result in cost savings in treatment programmes.</gtr:technicalSummary><gtr:fund><gtr:end>2015-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>0</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National University of Singapore</gtr:collaboratingOrganisation><gtr:country>Singapore, Republic of</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Electrical characterisation of DNA on silicon surfaces</gtr:description><gtr:id>0D6E5C1D-9330-4FE4-9AC9-E7461AA88559</gtr:id><gtr:impact>Newcastle University awarded the PI a Global Excellence Award (&amp;pound;10K) to build this relationship. Prof C Nijuis was the invited plenary speaker at the annual Chemical Nanoscience Symposium at Newcastle in 201 (CNSN-6).
Dr Pike has been invited to speak at the MRS-Singapore meeting in July 2017.
PhD student has been awarded travel funding from Santander to visit Singapore to complete experiments to fully characterise the DNA chips fabricated in Newcastle to investigate their suitability for possible early stage cancer detection.</gtr:impact><gtr:outcomeId>58c707fc547031.24704703-1</gtr:outcomeId><gtr:partnerContribution>Prof C Nijhiuis and his group at NUS are experts in electro-characterisation of self-assembled monolayers through a soft-tip approach method. The surfaces fabricated in Newcastle are characterised for the first time using this method in Singapore and may lead to the development of DNA mismatch detection.</gtr:partnerContribution><gtr:piContribution>DNA target sequences were immobilised onto silicon wafers using a technique developed but eh Q_CANCER projects which were then shipped to the National University of Singapore for some preliminary testing by the EGaIn technique developed there under the direction of Prof C Nijhuis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>72C89D6C-26CD-4B45-8402-7166DFE7272F</gtr:id><gtr:title>DNA-templated nanowires: morphology and electrical conductivity.</gtr:title><gtr:parentPublicationTitle>Nanoscale</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02b02af4c5cb60d12b0850cfeaa172f7"><gtr:id>02b02af4c5cb60d12b0850cfeaa172f7</gtr:id><gtr:otherNames>Watson SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2040-3364</gtr:issn><gtr:outcomeId>5460b517db6935.30636086</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_13031</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>5191BE6E-A234-4D62-A4F3-B50DBAAE8217</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.5  Resources and infrastructure (detection)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>